Aging Trends And Genomics Will Expand Autoimmune Treatment Opportunities

Published
27 Apr 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
€694.75
18.6% undervalued intrinsic discount
15 Aug
€565.60
Loading
1Y
21.7%
7D
2.1%

Author's Valuation

€694.8

18.6% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on06 Aug 25
Fair value Increased 4.44%

A sharp decline in argenx’s future P/E ratio, despite slightly lower revenue growth forecasts, has contributed to a notable increase in the consensus analyst price target from €665.23 to €700.31. What's in the News Argenx and Unnatural Products Inc.

Shared on01 May 25
Fair value Decreased 0.32%